Parkinson's competition heats up in Japan as rotigotine patch nears filing
This article was originally published in Scrip
Executive Summary
Otsuka Pharmaceutical is planning a Japanese approval submission for its rotigotine patch for Parkinson's disease following confirmation of the product's safety and efficacy in a local Phase III trial, stepping up the race between a number of new therapies.